Induction of paclitaxel resistance by ERα mediated prohibitin mitochondrial-nuclear shuttling.
Paclitaxel is a drug within one of the most promising classes of anticancer agents. Unfortunately, clinical success of this drug has been limited by the insurgence of cellular resistance. To address this, Paclitaxel resistance was modeled in an in vitro system using estrogen treated prostate cancer...
Guardado en:
Autores principales: | Pei Dong, Lijuan Jiang, Jianye Liu, Zhiming Wu, Shengjie Guo, Ziling Zhang, Fangjian Zhou, Zhuowei Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cac872817d27418e84e1b78a2020dc89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
por: Yingxue Bai, et al.
Publicado: (2021) -
Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance
por: Haohao Huang, et al.
Publicado: (2021) -
β2-adrenoreceptor agonist ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of mitochondrial biogenesis
por: Nan Chen, et al.
Publicado: (2021) -
Prohibitins are required for cancer cell proliferation and adhesion.
por: Claudia Sievers, et al.
Publicado: (2010) -
Hyperlipidemic hypersensitivity to lethal microbial inflammation and its reversal by selective targeting of nuclear transport shuttles
por: Yan Liu, et al.
Publicado: (2021)